Bruker Corporation (BRKR)
BRKR trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$56.19
-0.11% on the day
Market cap
$8.6B
Mid cap
Revenue · 2025
$3.4B
+2.1% on 2024
Net income · 2025
-$8.3M
-0.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BRKR on Nasdaq |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001109354 |
| SEC industry code | Laboratory Analytical Instruments |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $3.4B |
| Net income | -$8.3M |
| Operating income | $68.2M |
| Net margin | -0.2% |
| Operating margin | 2.0% |
| Revenue growth | +2.1% |
| Cash | $298.8M |
| Total assets | $6.2B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-06-12 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-14 |
| Latest proxy | DEFA14A | 2026-04-10 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -6.9% |
| 1 month | -0.3% |
| 3 months | -6.2% |
| Year to date | +18.0% |
| 1 year | +53.5% |
| From 52-week high | -14.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| BRKRP | Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A | $417.37 |
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TXG | 10x Genomics Inc. | $71.79 | -4.52% | $9.4B |
| BIO | Bio-Rad Laboratories Inc. | $363.73 | -0.19% | $9.7B |
| AVTR | Avantor Inc. | $15.55 | +0.39% | $10.5B |
| RVTY | Revvity Inc. | $155.08 | -0.34% | $17.3B |
| MTD | Mettler-Toledo International Inc. | $1598.03 | +2.24% | $32.0B |
| WAT | Waters Corporation | $429.17 | -0.68% | $42.2B |
| ALMR | Alamar Biosciences Inc. | $23.52 | -2.97% | $1.6B |
| A | Agilent Technologies Inc. | $171.60 | +0.16% | $48.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier